Abstract
Dermatomyositis (DM) represents an idiopathic inflammatory disorder with distinctive skin and muscle involvement. NXP2 (Nuclear Matrix Protein) antibodies positivity defines an uncommon subgroup of patients, with variable clinical outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
